Pitcairn Co. Lowers Stock Position in Cardinal Health, Inc. $CAH

Pitcairn Co. cut its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 44.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,819 shares of the company’s stock after selling 3,863 shares during the quarter. Pitcairn Co.’s holdings in Cardinal Health were worth $810,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Jones Financial Companies Lllp grew its holdings in shares of Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after acquiring an additional 14,034 shares in the last quarter. Atlantic Edge Private Wealth Management LLC lifted its holdings in Cardinal Health by 75.0% during the second quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after acquiring an additional 75 shares during the period. Vermillion & White Wealth Management Group LLC boosted its position in Cardinal Health by 55.0% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock worth $34,000 after purchasing an additional 71 shares during the last quarter. NewSquare Capital LLC grew its stake in Cardinal Health by 100.0% in the 2nd quarter. NewSquare Capital LLC now owns 214 shares of the company’s stock valued at $36,000 after purchasing an additional 107 shares during the period. Finally, AlphaCore Capital LLC purchased a new stake in shares of Cardinal Health during the 2nd quarter valued at $41,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Up 0.9%

CAH stock opened at $200.03 on Tuesday. The firm has a 50 day moving average of $187.66 and a 200-day moving average of $167.12. The firm has a market capitalization of $47.53 billion, a P/E ratio of 30.17, a price-to-earnings-growth ratio of 1.44 and a beta of 0.63. Cardinal Health, Inc. has a 12 month low of $114.60 and a 12 month high of $214.93.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The business had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. During the same quarter in the prior year, the firm posted $1.88 EPS. Cardinal Health’s revenue was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Sell-side analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be issued a $0.5107 dividend. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio (DPR) is presently 30.77%.

Wall Street Analyst Weigh In

CAH has been the topic of a number of research analyst reports. TD Cowen boosted their price target on shares of Cardinal Health from $183.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, November 3rd. Jefferies Financial Group set a $220.00 target price on shares of Cardinal Health and gave the company a “buy” rating in a research report on Monday, November 3rd. Weiss Ratings restated a “buy (b)” rating on shares of Cardinal Health in a research note on Wednesday, October 8th. Leerink Partners upped their price objective on Cardinal Health from $211.00 to $230.00 and gave the company an “outperform” rating in a research note on Monday, November 17th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on Cardinal Health from $195.00 to $208.00 and gave the stock a “hold” rating in a research report on Tuesday, November 18th. Thirteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and an average price target of $209.00.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.